8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)
Published . Updated .
Key takeaways
- 8-K - ClearPoint Neuro filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
- Exposed: CLPT
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - ClearPoint Neuro filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
Directly affected
- CLPT ClearPoint Neuro-23.1% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that ClearPoint Neuro belongs to, so it often moves with news about it.
- SYK Stryker+16.7% 30d
Stryker is a peer of ClearPoint Neuro in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+15.1% 30d
3M is a peer of ClearPoint Neuro in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific+3.8% 30d
Boston Scientific is a peer of ClearPoint Neuro in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+19.7% 30d
Becton, Dickinson and is a peer of ClearPoint Neuro in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline+9.3% 30d
Medline is a peer of ClearPoint Neuro in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CLPT | +10.26% | +7.79% | base | after close | after close | after close | after close |
| XLV | +3.66% | +3.71% | base | after close | after close | after close | after close |
| SYK | -1.77% | -2.32% | base | after close | after close | after close | after close |
| MMM | +3.00% | +0.42% | base | after close | after close | after close | after close |
| BSX | +1.32% | +0.13% | base | after close | after close | after close | after close |
| BDX | -0.12% | +0.16% | base | after close | after close | after close | after close |
| MDLN | +2.09% | -0.03% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-18 AccNo: 0001193125-26-467272 Size: 198 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
ClearPoint Neuro (CLPT) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| BDX | three days earlier | +0.16% | final price |
| BDX | five days earlier | -0.12% | final price |
| BSX | three days earlier | +0.13% | final price |
| BSX | five days earlier | +1.32% | final price |
| ClearPoint Neuro (CLPT) | three days earlier | +7.79% | final price |
| ClearPoint Neuro (CLPT) | five days earlier | +10.26% | final price |
| MDLN | three days earlier | -0.03% | final price |
| MDLN | five days earlier | +2.09% | final price |
| MMM | three days earlier | +0.42% | final price |
| MMM | five days earlier | +3.00% | final price |
| SYK | three days earlier | -2.32% | final price |
| SYK | five days earlier | -1.77% | final price |
| XLV | three days earlier | +3.71% | final price |
| XLV | five days earlier | +3.66% | final price |
Congressional trades in the stocks in this story
- Rep. Thomas H. Kean Jr sold Stryker (SYK), worth $1,001 - $15,000 on 30 Sep 2026. That is 49 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 68 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 70 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 75 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 76 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)”
Companies carried with this story
- CLPT ClearPoint Neuro
For “8-K - ClearPoint Neuro, Inc. (0001285550) (Filer),” ClearPoint Neuro (CLPT) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> CLPT
How “8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)” reaches ClearPoint Neuro (CLPT)
“8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)” (18 Nov 2026) reaches ClearPoint Neuro (CLPT) through this story.
ClearPoint Neuro (CLPT) is on the page because SEC 8-K filing -> direct issuer disclosure -> CLPT
Dates and price levels for ClearPoint Neuro (CLPT)
CLPT traded between 8.30 and 11.94 across 20 sessions. The latest close on file is 8.48.
How solid “8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)” looks
14 out of 100
“8-K - ClearPoint Neuro, Inc. (0001285550) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.